臨床醫學研究所

Medicine & Life Sciences

1. Neoplasms 74%
2. interleukin 20 52%
3. Pancreatic Neoplasms 47%
4. Survival 40%
5. Therapeutics 38%
6. Lung Neoplasms 36%
7. Peroxisome Proliferator-Activated Receptors 31%
8. Adenocarcinoma 30%
9. Genes 29%
10. Inflammation 29%
11. Stomach Neoplasms 28%
12. gemcitabine 28%
13. Phosphorylation 27%
14. Proteins 27%
15. Adenocarcinoma of Lung 26%
16. Mutation 25%
17. Cohort Studies 25%
18. Growth 24%
19. Non-Small Cell Lung Carcinoma 23%
20. Pancreaticoduodenectomy 23%
21. Population 22%
22. Solitary Nucleus 20%
23. Cytokines 20%
24. Drug Therapy 20%
25. Wounds and Injuries 19%
26. Biomarkers 19%
27. Alzheimer Disease 19%
28. MicroRNAs 18%
29. Phosphatidylinositol 3-Kinase 18%
30. Stroke 18%
31. Glycogen Synthase Kinase 3 18%
32. Schizophrenia 17%
33. Acute Coronary Syndrome 17%
34. Kidney 17%
35. Reactive Oxygen Species 17%
36. Stem Cells 17%
37. Catenins 17%
38. Liver 16%
39. Incidence 16%
40. Obesity 16%
41. Skin 16%
42. Cell Line 16%
43. Macrophages 16%
44. Fluorouracil 15%
45. Irinotecan 15%
46. Down-Regulation 15%
47. Hypertension 15%
48. Confidence Intervals 15%
49. In Vitro Techniques 15%
50. Insulin Resistance 15%
51. Safety 15%
52. Mortality 15%
53. Hydroxymethylglutaryl-CoA Reductase Inhibitors 15%
54. Insulin 14%
55. Leucovorin 14%
56. Carcinoma 14%
57. Protein-Tyrosine Kinases 13%
58. Cell Movement 13%
59. Gastropoda 13%
60. Stomach 13%
61. Hepatocellular Carcinoma 13%
62. Blood Pressure 13%
63. Carcinogenesis 13%
64. Lung 12%
65. Brain 12%
66. Regeneration 12%
67. Gastrointestinal Stromal Tumors 12%
68. Infections 12%
69. ErbB Receptors 12%
70. Osteopontin 12%
71. quinoline 12%
72. Interleukin-1 12%
73. Mouth Neoplasms 12%
74. Cardiac Myocytes 11%
75. Esophageal Squamous Cell Carcinoma 11%
76. Monoclonal Antibodies 11%
77. Serum 11%
78. Neurons 11%
79. Renal Dialysis 11%
80. Chronic Renal Insufficiency 11%
81. Lipids 11%
82. Messenger RNA 11%
83. Phosphatidylinositols 11%
84. Antibodies 11%
85. collapsin response mediator protein-1 11%
86. Atrial Fibrillation 11%
87. Retrospective Studies 11%